Literature DB >> 4023557

Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel.

J Knobloch, E Delgado, A Alvarez, U Reymann, R Bialek.   

Abstract

In a prospective study 34 Peruvian fascioliasis patients were followed up for three months after treatment with praziquantel. The rapid sedimentation of faeces was demonstrated to be the most appropriate parasitological technique for the diagnosis of Fasciola hepatica infections in man compared to the MIF concentration or the examination of duodenal fluid by Enterotest. After therapy with different doses of praziquantel only 21% of the patients stopped to excrete worm eggs although 17 patients had been treated repeatedly. During the period of observation all patients presented a decreasing number of symptoms. It is concluded that praziquantel is not very active against F. hepatica in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4023557

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  12 in total

1.  Update on Hepatobiliary and Pulmonary Flukes.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

Review 2.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

3.  Seroprevalence of fascioliasis in the eastern region of Turkey: an eight-year investigation.

Authors:  Yunus Emre Beyhan; Hasan Yılmaz
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

4.  Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.

Authors:  S Carnevale; M I Rodríguez; G Santillán; J H Labbé; M G Cabrera; E J Bellegarde; J N Velásquez; J E Trgovcic; E A Guarnera
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

5.  Praziquantel failure in the treatment of Fasciola hepatica.

Authors:  D M Patrick; J Isaac-Renton
Journal:  Can J Infect Dis       Date:  1992-01

6.  Direct, immunological and molecular techniques for a fasciolosis survey in a rural area of San Luis, Argentina.

Authors:  Silvana Carnevale; Marta Graciela Cabrera; Marcela Alejandra Cucher; Cecilia Alicia di Risio; Jorge Bruno Malandrini; Laura Kamenetzky; Marcio Alazraqui; Cristina Beatriz Etchart; María Laura Pantano; Jorge Néstor Velásquez
Journal:  J Parasit Dis       Date:  2012-09-28

Review 7.  Studies on helminthosis at the Centre for Tropical Veterinary Medicine (CTVM).

Authors:  L J Harrison; J A Hammond; M M Sewell
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

8.  Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.

Authors:  A Marcilla; J E De la Rubia; J Sotillo; D Bernal; C Carmona; Z Villavicencio; D Acosta; J Tort; F J Bornay; J G Esteban; R Toledo
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

9.  Evaluation of the diagnostic efficacy of Fasciola adult worm vomit for serodiagnosis of human fasciolosis.

Authors:  Mahmoud Mohamed Elsibaei; Nehad Mahmoud Ali; Ayman Nabil Ibrahim; Basant Osama Mohammed
Journal:  Parasitol Res       Date:  2013-03-20       Impact factor: 2.289

10.  Spread of the fascioliasis endemic area assessed by seasonal follow-up of rDNA ITS-2 sequenced lymnaeid populations in Cajamarca, Peru.

Authors:  J N Bardales-Valdivia; M D Bargues; C Hoban-Vergara; C Bardales-Bardales; C Goicochea-Portal; H Bazán-Zurita; J Del Valle-Mendoza; P Ortiz; S Mas-Coma
Journal:  One Health       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.